“Since childhood, I have been fascinated by the immune system

and methods aimed at reinforcing to better fight diseases. I am very glad to work at Celyad Oncology and be part of the journey towards providing cancer therapies based on immune cells that could have a real impact on patient’s lives. The R&D team is working actively to develop innovative technologies or new platforms to push the cellular immunotherapy field a little further. In this aspect we differentiate from others in the field, by developing new targets and non-gene editing technologies to eventually propose in the near future new treatment options that would benefit a larger patient population. ”